Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Abstract Introduction: Acute coronary syndrome (ACS) remains a leading cause of mortality and disability worldwide. Vulnerable plaques constitute a key pathological substrate underlying ACS. Although lipid-lowering therapy (LLT) is central to plaque stabilization and secondary prevention in ACS, a substantial proportion of patients fail to achieve recommended lipid targets, underscoring a persistent gap between guideline recommendations and real-world outcomes.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
